Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma
Abstract Metastatic melanoma can be treated with anti-PD-1 monotherapy or in combination with anti-CTLA-4 or anti-Lag3. However, combination therapy is associated with a high risk of toxicity. Recently, we reported that high plasma soluble CD27 (sCD27) levels reflect the intratumoral interaction of...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Nature
2025-03-01
|
| coleção: | EMBO Molecular Medicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1038/s44321-025-00203-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
